Global Influenza Therapeutics Market

  1. Global Influenza Therapeutics Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Influenza Therapeutics Market – Market Definition and Overview

  3. Global Influenza Therapeutics Market – Executive Summary

    1. Market Snippet by Therapy Type

    2. Market Snippet by End User

    3. Market Snippet by Region

    4. DataM CLO Scenario

  4. Global Influenza Therapeutics Market – Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. Rise in prevalence of influenza

        2. Growth in geriatric population

        3. Increase in government funding

      2. Restraints

        1. Low healthcare awareness

      3. Opportunity

      4. Impact Analysis

  5. Global Influenza Therapeutics Market – Industry Analysis 

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Epidemiology

  6. Global Influenza Therapeutics Market – Pipeline Analysis 

  7. Global Influenza Therapeutics Market – By Therapy Type

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

      2.  Market Attractiveness Index, By Therapy Type

    2. Vaccines

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

      3. Trivalent

      4. Quadrivalent

    3.  Antiviral Drugs

      1.  Zanamivir

      2.  Oseltamivir

      3.  Peramivir

  8. Global Influenza Therapeutics Market – By End User

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User 

      2. Market Attractiveness Index, By End User

    2. Hospital Pharmacies

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    3.  Retail Pharmacies

    4.  Online Pharmacies

  9. Global Influenza Therapeutics Market – By Region

    1. Introduction 

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia-Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. The Middle East and Africa

    7. Introduction

    8. Key Region-Specific Dynamics

    9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type

    10. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

  10. Global Market – Competitive Landscape

    1. Competitive Scenario

    2. Competitor Influenza Therapeutics Strategy Analysis

    3. Comparative Product Portfolio Analysis

    4. Market Positioning/Share Analysis

    5. Mergers and Acquisitions Analysis

  11. Global Market – Company Profiles

    1. Abbott Laboratories Limited *

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. Astrazeneca Plc

    3. Biocryst Pharmaceuticals Inc.

    4. CSL Limited

    5. Daiichi Sankyo Co. Ltd.

    6. GlaxoSmithKline Plc

    7. Mitsubishi Tanabe Pharma Corporation

    8. Nanotherapeutics Inc.

    9. Protein Sciences Corporation

    10. Roche Holding AG

    11. Sanofi SA

    12. Shionogi & Co. Ltd.

    13. Sinovac Biotech Ltd.

    14. Luminex Corporation

    15. Mylan N.V.

    16. Orasure Technologies Inc.

    17. Quidel Corporation

    18. Seqirus GmbH

    19. Novartis AG

  12. Global Influenza Therapeutics Market – Premium Insights

  13. Global Influenza Therapeutics Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

Guide this sample report to your Inbox

Please fill in all the fields below.

Note: Your privacy is important to us. Any information you provide to us is stored on our secure servers.

List of Tables

Table 1 Global Influenza Therapeutics Market Value, By Therapy Type, 2018,2022 & 2026 ($ Million)

Table 2 Global Influenza Therapeutics Market Value, By End User, 2018,2022 & 2026 ($ Million)

Table 3 Global Influenza Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 4 Global Influenza Therapeutics Market Value, By Therapy Type, 2018,2022 & 2026 ($ Million)

Table 5 Global Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 6 Global Influenza Therapeutics Market Value, By End User, 2018,2022 & 2026 ($ Million)

Table 7 Global Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 8 Global Influenza Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 9 Global Influenza Therapeutics Market Value, By Region, 2017-2026 ($ Million)

Table 10 North America Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 11 North America Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 12 North America Influenza Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 13 South America Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 14 South America Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 15 South America Influenza Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 16 Europe Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 17 Europe Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 18 Europe Influenza Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 19 Asia-Pacific Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 20 Asia-Pacific Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 21 Asia-Pacific Influenza Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 22 Middle East & Africa Influenza Therapeutics Market Value, By Therapy Type, 2017-2026 ($ Million)

Table 23 Middle East & Africa Influenza Therapeutics Market Value, By End User, 2017-2026 ($ Million)

Table 24 Abbott Laboratories Limited: Overview

Table 25 Abbott Laboratories Limited: Product Portfolio

Table 26 Abbott Laboratories Limited: Key Developments

Table 27 Astrazeneca Plc: Overview

Table 28 Astrazeneca Plc: Product Portfolio

Table 29 Astrazeneca Plc: Key Developments

Table 30 Biocryst Pharmaceuticals Inc.: Overview

Table 31 Biocryst Pharmaceuticals Inc.: Product Portfolio

Table 32 Biocryst Pharmaceuticals Inc.: Key Developments

Table 33 CSL Limited: Overview

Table 34 CSL Limited: Product Portfolio

Table 35 CSL Limited: Key Developments

Table 36 Daiichi Sankyo Co. Ltd: Overview

Table 37 Daiichi Sankyo Co. Ltd: Product Portfolio

Table 38 Daiichi Sankyo Co. Ltd: Key Developments

Table 39 GlaxoSmithKline Plc: Overview

Table 40 GlaxoSmithKline Plc: Product Portfolio

Table 41 GlaxoSmithKline Plc: Key Developments

Table 42 Mitsubishi Tanabe Pharma Corporation: Overview

Table 43 Mitsubishi Tanabe Pharma Corporation: Product Portfolio

Table 44 Mitsubishi Tanabe Pharma Corporation: Key Developments

Table 45 Nanotherapeutics Inc.: Overview

Table 46 Nanotherapeutics Inc.: Product Portfolio

Table 47 Nanotherapeutics Inc.: Key Developments

Table 48 Protein Sciences Corporation: Overview

Table 49 Protein Sciences Corporation: Product Portfolio

Table 50 Protein Sciences Corporation: Key Developments

Table 51 Roche Holding AG: Overview

Table 52 Roche Holding AG: Product Portfolio

Table 53 Roche Holding AG: Key Developments

List of Figures

Figure 1 Global Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 2 Global Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 3 Global Influenza Therapeutics Market Share, By Region, 2018 & 2026 (%)

Figure 4 Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 5 Global Influenza Therapeutics Market Y-o-Y Growth, By Therapy Type, 2018-2026 (%)

Figure 6 Vaccines: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 7 Antiviral Drugs: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 8 Trivalent: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 9 Quadrivalent: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 10 Zanamivir: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 11 Oseltamivir: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 12 Peramivir: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 13 Global Influenza Therapeutics Market Y-o-Y Growth, By End User, 2018-2026 (%)

Figure 14 Hospital Pharmacies: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 15 Retail Pharmacies: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 16 Online Pharmacies: Global Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 17 Global Influenza Therapeutics Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 18 North America Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 19 North America Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 20 North America Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 21 North America Influenza Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 22 South America Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 23 South America Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 24 South America Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 25 South America Influenza Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 26 Europe Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 27 Europe Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 28 Europe Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 29 Europe Influenza Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 30 Asia-Pacific Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 31 Asia-Pacific Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 32 Asia-Pacific Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 33 Asia-Pacific Influenza Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 34 Middle East & Africa Influenza Therapeutics Market Value, 2017-2026 ($ Million)

Figure 35 Middle East & Africa Influenza Therapeutics Market Share, By Therapy Type, 2018 & 2026 (%)

Figure 36 Middle East & Africa Influenza Therapeutics Market Share, By End User, 2018 & 2026 (%)

Figure 37 Abbott Laboratories Limited: Financials

Figure 38 Astrazeneca Plc: Financials

Figure 39 Biocryst Pharmaceuticals Inc.: Financials

Figure 40 CSL Limited: Financials

Figure 41 Daiichi Sankyo Co. Ltd: Financials

Figure 42 GlaxoSmithKline Plc: Financials

Figure 43 Mitsubishi Tanabe Pharma Corporation: Financials

Figure 44 Nanotherapeutics Inc.: Financials

Figure 45 Protein Sciences Corporation: Financials

Figure 46 Roche Holding AG: Financials

 
Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report